GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $48,520,000 | -2.9% | 1,000,000 | +5.3% | 2.02% | +17.2% |
| Q2 2019 | $49,970,000 | -0.6% | 950,000 | 0.0% | 1.73% | -20.6% |
| Q1 2019 | $50,284,000 | +250.0% | 950,000 | +171.4% | 2.17% | +153.1% |
| Q4 2018 | $14,368,000 | +31.5% | 350,000 | +21.7% | 0.86% | +71.1% |
| Q3 2018 | $10,925,000 | -65.5% | 287,500 | -59.0% | 0.50% | -58.8% |
| Q2 2018 | $31,665,000 | -63.5% | 700,548 | -63.5% | 1.22% | -70.6% |
| Q1 2018 | $86,720,000 | +19.6% | 1,917,548 | +4.1% | 4.14% | -11.9% |
| Q4 2017 | $72,479,000 | +107.6% | 1,841,896 | +63.8% | 4.70% | +73.5% |
| Q3 2017 | $34,910,000 | +48.4% | 1,124,300 | +30.7% | 2.71% | -8.8% |
| Q2 2017 | $23,521,000 | -21.7% | 860,000 | +5.5% | 2.97% | -22.6% |
| Q1 2017 | $30,033,000 | +108.7% | 815,000 | -18.2% | 3.84% | +32.0% |
| Q4 2016 | $14,390,000 | -28.2% | 995,838 | +14.6% | 2.91% | -17.3% |
| Q3 2016 | $20,037,000 | +25.3% | 869,263 | -9.8% | 3.52% | -1.0% |
| Q2 2016 | $15,987,000 | +384.5% | 963,646 | +363.1% | 3.55% | +208.7% |
| Q1 2016 | $3,300,000 | – | 208,086 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |